Cargando…
Keap1–Nrf2 pathway: A promising target towards lung cancer prevention and therapeutics
OBJECTIVES: Drugs for targeted therapy have become a new strategy of adjuvant therapy for treatment of lung cancer. The Keap1 (kelch-like ECH-associated protein 1)–Nrf2 (nuclear factor erythroid 2-related factor 2) pathway is recognized to be critical in regulating genes related to the cellular prot...
Autores principales: | Tong, Ying-Hui, Zhang, Bo, Fan, Yun, Lin, Neng-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
KeAi Publishing
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5643752/ https://www.ncbi.nlm.nih.gov/pubmed/29063005 http://dx.doi.org/10.1016/j.cdtm.2015.09.002 |
Ejemplares similares
-
Keap1/Nrf2 Signaling Pathway
por: Sykiotis, Gerasimos P.
Publicado: (2021) -
KEAP1 and done? Targeting the NRF2 pathway with sulforaphane
por: Dinkova-Kostova, Albena T., et al.
Publicado: (2017) -
Nrf2/Keap1/ARE signaling: Towards specific regulation
por: Ulasov, Alexey V., et al.
Publicado: (2022) -
Carnosic acid prevents dextran sulfate sodium-induced acute colitis associated with the regulation of the Keap1/Nrf2 pathway
por: Yang, Neng, et al.
Publicado: (2017) -
Epigenetic Therapeutics Targeting NRF2/KEAP1 Signaling in Cancer Oxidative Stress
por: Zhang, Shunhao, et al.
Publicado: (2022)